Discovery of Tropifexor (LJN452), a Highly Potent Non-bile Acid FXR Agonist for the Treatment of Cholestatic Liver Diseases and Nonalcoholic Steatohepatitis (NASH).
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Phil B Alper Sean Joseph David C Tully Bryan Laffitte |
| Publication date | November 16, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |